Net Medical Xpress Solutions Inc 最近的每股收益为 $, $ 的预期。
Net Medical Xpress Solutions Inc NMXS 上一季度的收入表现如何?
Net Medical Xpress Solutions Inc 上一季度的收入为 $
Net Medical Xpress Solutions Inc 的收入预期是多少?
根据 位华尔街分析师的预测,Net Medical Xpress Solutions Inc 的收入预期范围从 $ 到 $
Net Medical Xpress Solutions Inc 的盈利质量评分是多少?
Net Medical Xpress Solutions Inc 的盈利质量评分为 B+/44.415165。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Net Medical Xpress Solutions Inc 何时发布财报?
Net Medical Xpress Solutions Inc 的下一份财报预计在 发布
Net Medical Xpress Solutions Inc 的预期收益是多少?
根据华尔街分析师的预测,Net Medical Xpress Solutions Inc 的预期收益为 $
Net Medical Xpress Solutions Inc 是否超出收益预期?
Net Medical Xpress Solutions Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0007
开盘价
$0.0001
当日区间
$0.0001 - $0.0007
52周范围
$0 - $0.0095
交易量
132
平均成交量
61.5K
股息收益率
--
每股收益(TTM)
-0.02
市值
$26.3K
什么是 NMXS?
Net Medical Xpress Solutions, Inc. engages in the provison of solutions for the telemedicine industry. The company is headquartered in Albuquerque, New Mexico. The company went IPO on 2000-11-22. The firm is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. The company focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. The company offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.